In phase II clinical trials involving 285 RA patients, VX-740 showed a trend toward symptom improvement but failed to reach statistical significance.
← all excerpts
Osteoarthritis: molecular pathogenesis and potential therapeutic options.
1
—
—
In phase II clinical trials involving 285 RA patients, VX-740 showed a trend toward symptom improvement but failed to reach statistical significance.